Global OncoThon 2026 LIVE DONATE to strengthen the continuum of oncology care

Razelle Kurzrock: Antibody–Drug Conjugates and Targeted Cytotoxic Delivery to Leptomeningeal Disease

Highlights from ELLOK Annual Conference 2026: The Power of Words in Cancer Communication

Claudin 18.2 Expression in Gastroesophageal Adenocarcinoma: Biomarker Overlap and Association With Clinical Outcomes in a European Cohort

Aleix Prat: Integrating Baseline and On-Treatment Tumor Biology in Precision Breast Cancer Care

Oncology News, Insights, Stories by OncoDaily

Global Oncothon
OncoDaily

Global Oncothon 2026

Jigjidsuren Chinburen
OncoDaily Magazine

Jigjidsuren Chinburen: Building Cancer Care With Patience and Honesty

FDA Grants Priority Review to Datopotamab Deruxtecan for First-Line Immunotherapy-Ineligible Metastatic TNBC
Oncolibrary

FDA Grants Priority Review to Datopotamab Deruxtecan for First-Line Immunotherapy-Ineligible Metastatic TNBC

Highlights from ELLOK Annual Conference 2026: Health Literacy in Focus: Opportunities and Challenges

OncoThon 2026: Global Voices on Equity, Data, and Survivorship

Julie Gralow։ New ASCO Living Guideline in MCRPC

Recognizing the 29 Recipients of IDEA 2026 - Conquer Cancer

Patriots DC Terrell Williams Declared Cancer‑Free After Prostate Cancer Battle

Arjun Balar Joins Eli Lilly as SVP of Oncology Clinical Development

Gevorg Tamamyan: The Story of Life and Leadership of Shreeram Aradhye

OncoThon 2026
Advances in The Immunotherapy of Cold Tumors
OncoDaily 100
Act 4 Children
Grand Rounds GI
OncoDaily Party: Berlin 2025
awards
awards
awards
awards
awards
awards

Voices
Agnes Viale

Agnes Viale: Reflecting on 20 Years of Progress at MSK’s Human Oncology and Pathogenesis Program

One Challenge, Growing Hope: Ishtar Espejo Takes On the Global OncoThon 2026 Challenge

Carmen Uscatu: Carrying Hope Forward - Collaborating with Prinses Máxima Centrum and Marie Curie Children’s Hospital

When Humanity Leads, Technology Can Truly Transform Cancer Care - Microsoft for Nonprofits

Myeloma Paper of the Day, February 4th, Suggested by Robert Orlowski

Ravindran Kanesvaran: Singapore Cancer Society Launches Cancer Care Coalition at Screen Fest 2026

While the Science Is Global, the Care Must Be Individual – Supporting the United by Unique Theme - SPCC

FDA Approvals
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy

FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC

FDA Approved Rucaparib for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer

FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer

New Hope for NUT Carcinoma: FDA Grants Orphan Drug Status to ZEN-3694

FDA approved Durvalumab plus FLOT for resectable gastric or GEJ adenocarcinoma

OncoDaily 100
100 Most Influential CEOs

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

British Society of Haematology Supportive Care Specialist Interest Group (SIG) Prioritisation Workshop

British Society of Haematology

25 Feb
British Society of Haematology

Escalation or De-Escalation? Strategies in HER2+ Breast Cancer Treatment

Sharing Progress in Cancer Care

23 Apr
Breast Cancer Treatment

38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026)

European Organisation for Research and Treatment of Cancer

18 Nov
EORTC-NCI-AACR

Clinical Trial Statistics for Non-Statisticians Workshop

European Organisation for Research and Treatment of Cancer

09 Jun
Clinical Trial Statistics

15th European Breast Cancer Conference (EBCC-15)

European Organisation for Research and Treatment of Cancer

25 Mar
Breast Cancer Conference

Immune-oncology
10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The "Off-the-Shelf" Revolution: How iNKT Cell Therapy agenT-797 is Reprogramming the Fight Against Solid Tumors

10 Posts Not to Miss from ESMO

OncoDaily TV
Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

minister

When Minister is also your treating Doctor – Hosams Abu Meri

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Dr. Navid Madani

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Prof. Kofi Mensah Nyarko

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Mina S. Sedrak

Mina S. Sedrak: Shaping the Future of Cancer and Aging Research, Redefining Survivorship

Yuman Fong

Yuman Fong: Exclusive Interview on Innovation, Mentorship and the Future of Surgical Oncology

Immunotherapy in Nigeria

Opening New Frontiers for Cancer Care in Africa: Bringing Colorectal Cancer Immunotherapy in Nigeria

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

Gregory Kalemkerian

60 questions about SCLC with Dr. Gregory Kalemkerian Part 1

Mohamed Osman

ONCOFFEE: Mohamed Osman – Building a Research Career from Egypt to New York

Susan G. Komen

How Is Susan G. Komen Changing the Future of Breast Cancer Care?

Not To Miss
ELLOK - OncoDaily

Highlights from ELLOK Annual Conference 2026: Health Literacy in Focus: Opportunities and Challenges

Highlights from ELLOK Annual Conference 2026: The Power of Words in Cancer Communication

Oncology This Week: OncoDaily Weekly Jan 26-31, 2026

"Building Bridges of Care” at the 10th Annual Conference of ELLOK

ELLOK to Host 10th Annual Conference on People-Centred Cancer Care in Athens 2026

Oncology This Week: OncoDaily Weekly Jan 19-25, 2026

Highlights from How I Treat Cervical Cancer in 2026

OncoGrants
Karolinska Translational Seed Grant in Oncology

Karolinska Translational Seed Grant in Oncology 2026

AECC Excellence Programs Oncology Funding

AECC Excellence Programs Oncology Funding 2026

AECC Cancer Prevention Biology Oncology Grant

AECC Cancer Prevention Biology Oncology Grant 2026

AECC INNOVA Oncology Innovation Grant

AECC INNOVA Oncology Innovation Grant 2026

Mays Cancer Center Summer Oncology Research Program

Mays Cancer Center Summer Oncology Research Program 2026

Cure Childhood Cancer Translation to CURE Oncology Award 2026

Cure Childhood Cancer Translation to CURE Oncology Award 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Denis Leonardo Fontes Jardim

Denis Leonardo Fontes Jardim

Oncologists Location São Paulo, Brazil
Md Imrul Kaes

Md Imrul Kaes

Oncologists Location Enayetpur, Bangladesh
Gabriëlle van Ramshorst

Gabriëlle van Ramshorst

Oncologists Location Ghent, Belgium
Tezer Kutluk

M. Tezer Kutluk

Oncologists Location Ankara, Türkiye
Jay M. Lee

Jay M. Lee

Oncologists Location Los Angeles, USA
Capucine Baldini

Capucine Baldini

Oncologists Location Villejuif, France
Khushali Jhaveri

Khushali Jhaveri

Oncologists Location Indianapolis, USA
Douglas Flora

Douglas Flora

Oncologists Location Edgewood, USA

Oncology Drugs
GSK5764227 (HS-20093): A New HER2-Targeted Treatment Being Studied in Cancer

GSK5764227 (HS-20093): A New HER2-Targeted Treatment Being Studied in Cancer

GSK5764227 (HS-20093): Clinical Development of a Next-Generation HER2-Directed Antibody–Drug Conjugate

Daraxonrasib (RMC-6236): Clinical Development of a RAS(ON) Inhibitor Advancing Precision Therapy in RAS-Driven Solid Tumors

Daraxonrasib (RMC-6236): A New Targeted Treatment Being Studied for RAS-Driven Cancers

Anbenitamab (KN026): A Patient-Friendly Guide to a New HER2-Targeted Treatment

Anbenitamab (KN026): A Deep Dive Into a Bispecific HER2 Antibody Redefining Targeted Therapy

Iza-Bren (EGFR×HER3 ADC): A Patient-Friendly Guide To A New Cancer Treatment

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
CATNON Trial

CATNON Final Analysis: Defining the Role of Adjuvant Temozolomide in IDH-Mutant Grade 3 Astrocytoma

JUPITER-06

JUPITER-06 Final Overall Survival and Genomic Biomarker Analysis in Advanced ESCC

JCOG0603

JCOG0603 Long-Term Results: Adjuvant mFOLFOX6 After Hepatectomy in Resectable Colorectal Liver Metastases

Nous-209 vaccine

New Paper Alert: Nous-209 Neoantigen Vaccine for Cancer Interception in Lynch Syndrome

LARA Trial

LARA Trial: Pembrolizumab–Lenvatinib in Recurrent Gynecologic Clear Cell Carcinoma

OPBC-07/microNAC

OPBC-07/microNAC: Oncological Outcomes With and Without Axillary Lymph Node Dissection in Patients with Residual Micrometastases After Neoadjuvant Chemotherapy.

OncoDaily Medical Journal

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7103

Dosimetric Comparison of 5-, 7-, and 9-Field SIB-IMRT Plans in Prostate Cancer Using 100% Isodose-Based Target Evaluation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6652

Radiation‐induced Lung Toxicity: A Crucial Problem in Thoracic Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7089

Hippocampus Sparing for Patients Undergoing Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma in Morocco: A Dosimetric Study
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6686

Optimizing Quality of Life in Cervical Cancer Survivors: A Comparative Study of Vaginal Doses Delivered Using Three HDR Brachytherapy Applicators
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6503

Assessment of MOSFET Detectors in In-Vivo Dosimetry for VMAT Total Body Irradiation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7028

A Novel Evaluation Formula for Plan Quality in Conventional Fractionated and Stereotactic Radiotherapy: Nabaa Efficiency Index (NEI)
Abstracts